← Back

National Health Investors: NHI's Strong Q4 2025 Earnings: A Closer Look

NHI reported a robust fourth quarter, with normalized FFO per share growth of 8.9% compared to the prior year, driven by the SHOP platform, which saw total NOI increase by 125% year over year and 48% sequentially. The company's net income per share was $0.80, a decrease of 15.8% from the prior year, while NAREIT FFO per share was $1.22, a decrease of 1.6% from the prior year. The actual EPS came out at $1.22 relative to estimates at $1.23. Normalized FFO per share for the full year increased 10.6% to $4.91, and total FAD growth was 13.7% to $232.1 million.

NHI

USD 84.07

-4.12%

A-Score: 6.8/10

Publication date: February 27, 2026

Author: Analystock.ai

📋 Highlights

Financial Performance

The company's financial performance was strong, with a fortress balance sheet and a net debt to adjusted EBITDA ratio of 3.8 times. The company's available liquidity was approximately $875 million, comprising cash on the balance sheet, excess revolver, forward equity, and additional ATM capacity. NHI's leverage policy has been lowered from a range of four to five times to a range of three and a half to four and a half times net debt to adjusted EBITDA.

SHOP Growth and Outlook

The SHOP platform continues to drive growth, with NOI increasing by approximately 57% compared to 2024, driven by 7.6% same-store growth and $6 million from transitions and acquisitions. The company expects near-term NOI growth in the high single-digit to low double-digit range, producing strong rates of return in the low to mid-teens. As Kevin Pascoe mentioned, "We expect that the acquisition environment will remain incredibly strong for several years," and NHI is well-positioned to capitalize on this trend.

Valuation and Dividend Yield

With a P/E Ratio of 27.72 and a Dividend Yield of 4.33%, NHI's valuation appears reasonable. The company's ROE is 9.63%, and its ROIC is 6.68%. The Net Debt / EBITDA ratio is -0.22, indicating a healthy debt position. Analysts estimate next year's revenue growth at 4.0%, which is relatively conservative compared to the company's historical performance.

Guidance and Outlook

NHI's guidance for 2026 includes $230 million in additional future investments at an average NOI yield of 7.8%, primarily in SHOP investments. The company expects NAREIT FFO and NFFO per share to grow 6.9% and 1.2%, respectively, and total FAD to grow 7.8% to $250.2 million. With a strong pipeline and a solid balance sheet, NHI is well-positioned for continued growth.

National Health Investors's A-Score